Table 3.
Patient comorbidities
| Prior to matching | After matching | |||||
|---|---|---|---|---|---|---|
| Comorbidity |
COVID + (n = 740) |
COVID – (n = 36 222) |
P |
COVID + (n = 736) |
COVID – (n = 736) |
P |
| Hypertension, n (%) | 180 (24.324) | 4366 (12.053) | 0.0001 | 176 (23.913) | 178 (24.185) | 0.9029 |
| Chronic lower lung disease, n (%) | 115 (15.541) | 3596 (9.928) | 0.0001 | 112 (15.217) | 106 (16.712) | 0.6597 |
| Diabetes mellitus, n (%) | 134 (18.108) | 2339 (6.457) | 0.0001 | 130 (15.217) | 123 (16.712) | 0.6287 |
| Ischemic heart disease, n (%) | 76 (10.27) | 1447 (3.995) | 0.0001 | 73 (9.918) | 66 (8.967) | 0.5327 |
| Chronic kidney disease, n (%) | 40 (5.405) | 899 (2.482) | 0.0001 | 40 (5.435) | 48 (6.522) | 0.3791 |
| Heart failure, n (%) | 53 (7.162) | 867 (2.394) | 0.0001 | 49 (6.658) | 50 (6.793) | 0.9171 |
| Cerebrovascular disease, n (%) | 68 (0.189) | 1068 (2.948) | 0.0001 | 64 (8.696) | 64 (8.696) | 1 |
| Nicotine dependence, n (%) | 140 (18.919) | 3975 (10.974) | 0.0001 | 136 (18.478) | 138 (16.712) | 0.8935 |
| Alcohol-related disorders, n (%) | 70 (9.459) | 1516 (4.185) | 0.0001 | 67 (9.103) | 66 (8.967) | 0.9276 |